⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LTRN News
Lantern Pharma Inc. Common Stock
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, and Global Workforce Technology
accessnewswire.com
VTIX
MDCX
YYGH
DVLT
LTRN
RDZN
IGC
Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers with NSCLC
businesswire.com
LTRN
Form 8-K
sec.gov
LTRN
Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates
businesswire.com
LTRN
Form 8-K
sec.gov
LTRN
Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
businesswire.com
LTRN
Lantern Pharma Inc. Announces Closing of up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
businesswire.com
LTRN
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
businesswire.com
LTRN
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
businesswire.com
LTRN
Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026
businesswire.com
LTRN